Abstract:Background:Obesity is considered a risk factor for the development of several neurodegenerative diseases, including Parkinson's disease (PD). Recent studies have revealed that glymphatic function is compromised in PD patients. This study aims to investigate the impact of different body mass index (BMI) statuses on glymphatic system function in PD patients using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) method.Methods:This study used a cross-sectional study design. A total of 145 PD patients were retrospectively enrolled in Parkinson's Progression Markers Initiative (PPMI) from 2010-2013. Eligibility criteria included diagnosis of PD based on PPMI criteria. Diffusion tensor image (DTI) scans (diffusion gradient =64, b-value =1,000 s/mm2, slice thickness =2 mm) were acquired, and the analysis along the perivascular space (ALPS) index of each subject was calculated. The patient cohort was categorized into three groups based on BMI: normal weight (N=49), overweight (N=69), and obese (N=27). The difference in ALPS index among groups was performed by one-way analysis of variance (ANOVA). Partial correlation analysis was used to observe the relationship between ALPS index, BMI status, and demographics. Spearman's rank correlation coefficient and multivariable linear regression analyses were used to identify factors associated with ALPS index.Results:PD patients with higher BMI exhibited a reduced ALPS index (normal weight > overweight > obese), and the ALPS index for patients with obesity was statistically significantly lower than that for patients with normal weight (P<0.001). After adjusting for age, sex, years of education, handedness, and disease duration, a significant negative correlation between the ALPS index and BMI was observed in the PD patients (R=-0.275, P<0.001). Furthermore, a negative correlation between the ALPS index and the severity of motor symptoms was identified in the subgroup of overweight (R=-0.318, P=0.01), rather than in the normal weight and obese groups.Conclusions:High BMI has a negative impact on the glymphatic function in PD patients, suggesting that weight control may have clinical relevance in the management of PD patients.

Gray matter reduction related to decreased serum creatinine and increased triglyceride, Hemoglobin A1C, and low-density lipoprotein in subjects with obesity

Gray Matter Volume Alterations in Subjects with Overweight and Obesity: Evidence from a Voxel-Based Meta-Analysis

Decrease of Gray Matter Volume in Treatment-Refractory Schizophrenia-Voxel Based Morphometry (VBM) Study

Altered Regional Gray Matter Volume in Obese Men: A Structural MRI Study.

Obesity is Associated with Decreased Gray Matter Volume in Children: a Longitudinal Study.

Abnormal of Inter-Hemispheric Functional Connectivity in Elderly Subjects with Overweight/obesity.

The interplay between white adipose tissue, adipokines, and structural gray matter changes

Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease

Reduced Gray Matter Volume in Patients with Type 2 Diabetes Mellitus.

Relationships Between Plasma Leptin Concentrations and Human Brain Structure: A Voxel-Based Morphometric Study

The Associations of Glycosylated Hemoglobin with Grey Matter Volume and Depression: Investigating Mediating Role of Grey Matter Volume

Fat-free body mass but not fat mass is associated with reduced gray matter volume of cortical brain regions implicated in autonomic and homeostatic regulation.

Gray matter reduction is associated with cognitive dysfunction in depressed patients comorbid with subclinical hypothyroidism

Associations Between High-Density Lipoprotein Cholesterol Efflux and Brain Grey Matter Volume

Association Between Body Mass Index and Glymphatic Function Using Diffusion Tensor Image-along the Perivascular Space (DTI-ALPS) in Patients with Parkinson’s Disease

Gray matter reduction in bilateral insula mediating adverse psychiatric effects of body mass index in schizophrenia

Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder

Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment

Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal Individuals

Gray and White Matter Structures in the Midcingulate Cortex Region Contribute to Body Mass Index in Chinese Young Adults

Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer's disease